Among all recommended biomarkers, the markers which are reported to be more sensitive than others in detecting AKI are neutrophil gelatinase-associated lipocalin (NGAL) and interleukin-18 (IL-18)[3]. This evidence concerns the gene IL18 and acute kidney injury.